UiPath Inc. (NYSE: PATH) saw its shares climb 9.8% over the last five sessions, closing Wednesday at $13.82. This level now matches the average analyst price target of $13.80, according to data from MarketBeat. The stock's recent rally, however, appears to be driven more by sector-wide momentum than company-specific catalysts.
The company's second-quarter guidance points to net new annual recurring revenue (ARR) of approximately $30.5 million, nearly identical to the $31 million reported in the same period last year. This suggests that UiPath's growth engine is decelerating, even as the broader AI software sector enjoys a resurgence.
The recent uptick in UiPath's share price coincided with a sharp rally in Palantir Technologies Inc. (NASDAQ: PLTR), which surged after reporting a near-doubling of quarterly revenue and raising its full-year forecast. On Tuesday, UiPath recorded its largest single-day gain, but trading volume on Wednesday was 1.55 times the 65-day average, hinting at possible profit-taking.
UiPath's second-quarter revenue midpoint is $397.5 million, representing a 9.8% year-over-year increase, down from the 17% growth achieved in the first quarter. Non-GAAP operating margin is projected at 18.9%, a sequential decline from 22.0% in Q1. These figures, based on initial estimates, indicate a cooling growth trajectory.
The company's first-quarter results were solid, with revenue climbing 17% and GAAP operating income reaching $28 million. CEO Daniel Dines noted that agentic products are "moving from pilot to production," signaling potential long-term opportunities. However, the near-term outlook remains subdued.
Valuation metrics offer some support. UiPath holds $1.42 billion in cash and securities, about 19% of its current market capitalization. The stock trades at approximately 3.8 times ARR and 4.1 times projected annual revenue, figures considered modest for the software sector. Yet, the average analyst price target implies no immediate upside.
Analyst sentiment is largely neutral, with 14 of 17 recommendations being "Hold" and only two "Buy." The average target price of $13.80 is essentially flat against the current share price. Needham's Scott Berg stands out with a $15 target, suggesting an 8.5% potential gain, but a quarter that merely meets guidance may not justify broader target revisions.
Investors will look to Appian Corp. (NASDAQ: APPN), which reports results before Thursday's open, for additional signals on workflow demand. Friday's U.S. employment report will also serve as a broader barometer for software valuations.
Risks remain, including a cautious outlook, potential renewal downturns, pricing pressures, or a broader software market decline. For UiPath, a steady ARR outcome near $1.932 billion would indicate stability, but a convincing beat is needed to sustain the recent rerating.
